Life’s essential 8 and mortality in US adults with metabolic dysfunction-associated steatotic liver disease

Abstract Background Metabolic dysfunction-associated steatotic liver disease (MASLD) is linked to increased all-cause mortality due to metabolic dysfunctions like obesity, diabetes, and cardiovascular diseases. This study examines the association between Life’s Essential 8 (LE8) scores and both all-...

Full description

Saved in:
Bibliographic Details
Main Authors: Yingying Zhang, Pingping Wang, Fan Tu, Hao Kang, Chengfeng Fu
Format: Article
Language:English
Published: BMC 2024-12-01
Series:BMC Public Health
Subjects:
Online Access:https://doi.org/10.1186/s12889-024-20919-6
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850100545322221568
author Yingying Zhang
Pingping Wang
Fan Tu
Hao Kang
Chengfeng Fu
author_facet Yingying Zhang
Pingping Wang
Fan Tu
Hao Kang
Chengfeng Fu
author_sort Yingying Zhang
collection DOAJ
description Abstract Background Metabolic dysfunction-associated steatotic liver disease (MASLD) is linked to increased all-cause mortality due to metabolic dysfunctions like obesity, diabetes, and cardiovascular diseases. This study examines the association between Life’s Essential 8 (LE8) scores and both all-cause and cardiovascular disease (CVD) mortality in MASLD participants. Methods Data from 5,916 MASLD participants in the NHANES (2005–2018) were analyzed. Associations between LE8 scores and all-cause and CVD mortality were assessed using Cox proportional hazards models, with follow-up until December 31, 2019. Dose-response relationships and survival differences were evaluated using Kaplan-Meier survival curves and Restricted Cubic Spline models. Results Over a median follow-up of 7.6 years, moderate and high LE8 scores were associated with 33% (HR: 0.67; 95% CI: 0.56–0.79) and 47% (HR: 0.53; 95% CI: 0.33–0.84) lower risk of all-cause mortality, respectively, compared to low scores. For CVD mortality, the adjusted HRs were 0.56 (95% CI: 0.41–0.78) and 0.35 (95% CI: 0.12-1.0). Higher LE8 scores were significantly associated with reduced cumulative incidence of all-cause and CVD mortality (log-rank P < 0.001). A 10-point increase in health behavior scores, particularly in diet, physical activity, and nicotine exposure, was linked to an 11% reduction in all-cause mortality risk and an 11% reduction in CVD mortality risk. Among health factors, only blood glucose showed a significant association with CVD mortality. Conclusion Higher LE8 scores in MASLD patients are associated with lower mortality risk, suggesting the potential value of promoting cardiovascular health in this population. Further research is needed to confirm these associations. Graphical Abstract
format Article
id doaj-art-b2dbe674ec394cf7ae23bb566c84571a
institution DOAJ
issn 1471-2458
language English
publishDate 2024-12-01
publisher BMC
record_format Article
series BMC Public Health
spelling doaj-art-b2dbe674ec394cf7ae23bb566c84571a2025-08-20T02:40:17ZengBMCBMC Public Health1471-24582024-12-0124111210.1186/s12889-024-20919-6Life’s essential 8 and mortality in US adults with metabolic dysfunction-associated steatotic liver diseaseYingying Zhang0Pingping Wang1Fan Tu2Hao Kang3Chengfeng Fu4Medical Laboratory Center, Affiliated Wuxi Fifth Hospital of Jiangnan UniversityDepartment of Clinical Laboratory, Taizhou Second People’s Hospital Affiliated to Yangzhou UniversityMedical Laboratory Center, Affiliated Wuxi Fifth Hospital of Jiangnan UniversityResearch Center for Clinical Medical Sciences, Affiliated Wuxi Fifth Hospital of Jiangnan UniversityRespiratory and Critical Care Medicine, The Second People’s Hospital of Banan DistrictAbstract Background Metabolic dysfunction-associated steatotic liver disease (MASLD) is linked to increased all-cause mortality due to metabolic dysfunctions like obesity, diabetes, and cardiovascular diseases. This study examines the association between Life’s Essential 8 (LE8) scores and both all-cause and cardiovascular disease (CVD) mortality in MASLD participants. Methods Data from 5,916 MASLD participants in the NHANES (2005–2018) were analyzed. Associations between LE8 scores and all-cause and CVD mortality were assessed using Cox proportional hazards models, with follow-up until December 31, 2019. Dose-response relationships and survival differences were evaluated using Kaplan-Meier survival curves and Restricted Cubic Spline models. Results Over a median follow-up of 7.6 years, moderate and high LE8 scores were associated with 33% (HR: 0.67; 95% CI: 0.56–0.79) and 47% (HR: 0.53; 95% CI: 0.33–0.84) lower risk of all-cause mortality, respectively, compared to low scores. For CVD mortality, the adjusted HRs were 0.56 (95% CI: 0.41–0.78) and 0.35 (95% CI: 0.12-1.0). Higher LE8 scores were significantly associated with reduced cumulative incidence of all-cause and CVD mortality (log-rank P < 0.001). A 10-point increase in health behavior scores, particularly in diet, physical activity, and nicotine exposure, was linked to an 11% reduction in all-cause mortality risk and an 11% reduction in CVD mortality risk. Among health factors, only blood glucose showed a significant association with CVD mortality. Conclusion Higher LE8 scores in MASLD patients are associated with lower mortality risk, suggesting the potential value of promoting cardiovascular health in this population. Further research is needed to confirm these associations. Graphical Abstracthttps://doi.org/10.1186/s12889-024-20919-6MASLDLife’s essential 8All-cause mortalityCVD mortalityNational health and nutrition examination survey
spellingShingle Yingying Zhang
Pingping Wang
Fan Tu
Hao Kang
Chengfeng Fu
Life’s essential 8 and mortality in US adults with metabolic dysfunction-associated steatotic liver disease
BMC Public Health
MASLD
Life’s essential 8
All-cause mortality
CVD mortality
National health and nutrition examination survey
title Life’s essential 8 and mortality in US adults with metabolic dysfunction-associated steatotic liver disease
title_full Life’s essential 8 and mortality in US adults with metabolic dysfunction-associated steatotic liver disease
title_fullStr Life’s essential 8 and mortality in US adults with metabolic dysfunction-associated steatotic liver disease
title_full_unstemmed Life’s essential 8 and mortality in US adults with metabolic dysfunction-associated steatotic liver disease
title_short Life’s essential 8 and mortality in US adults with metabolic dysfunction-associated steatotic liver disease
title_sort life s essential 8 and mortality in us adults with metabolic dysfunction associated steatotic liver disease
topic MASLD
Life’s essential 8
All-cause mortality
CVD mortality
National health and nutrition examination survey
url https://doi.org/10.1186/s12889-024-20919-6
work_keys_str_mv AT yingyingzhang lifesessential8andmortalityinusadultswithmetabolicdysfunctionassociatedsteatoticliverdisease
AT pingpingwang lifesessential8andmortalityinusadultswithmetabolicdysfunctionassociatedsteatoticliverdisease
AT fantu lifesessential8andmortalityinusadultswithmetabolicdysfunctionassociatedsteatoticliverdisease
AT haokang lifesessential8andmortalityinusadultswithmetabolicdysfunctionassociatedsteatoticliverdisease
AT chengfengfu lifesessential8andmortalityinusadultswithmetabolicdysfunctionassociatedsteatoticliverdisease